Furthermore, Gerhauser et al., (2018) demonstrated the role of androgen receptor-driven rearrangements, an early APOBEC-driven mutational mechanism, and ESRP1 gene duplication that contributed to the pathogenesis seen in early-onset prostate cancer. Here, ESRP1 is linked to prostate carcinoma.